Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmaco-epidemiological Observational Study of the Clinical Benefit of NeoRecormon® in Cancer Patients With Anemia, According to Early Response to Treatment

NCT01168349 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01168349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01168349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmaco-epidemiological Observational Study of the Clinical Benefit of NeoRecormon® in Cancer Patients With Anemia, According to Early Response to Treatment
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2010
Enrollment
1,060 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, neoplasms